Delivery Order SPE2DR25D7066-SPE2DR26F7ZVF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,808.45 to AmerisourceBergen Drug Corp for 500 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in emergency medical settings. This firm fixed price delivery order, issued on December 31, 2025, is expected to be completed by January 23, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order placed under...
- This federal contract award is for the delivery of Kcentra 500 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed price basis. The contract has a ceiling value of $4,478.70 and an ultimate completion date of July 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00,...
- This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order valued at $7,464.50, with an ultimate completion date of June 18, 2024. The contract is for the supply of 4,564,731,232 units of KCENTRA 500 UNIT VIALS. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $3,732.25 firm-fixed-price delivery order is for the supply of 4,564,814,393 units of the blood-clotting medication KCENTRA 500 UNIT VIALS. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,492.90 fixed-price delivery order is for the supply of KCENTRA 500 unit vials, a pharmaceutical product. The contract has a completion date of May 15, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of the large pharmaceutical distributor AmerisourceBergen Corporation, holds a significant Indefinite Delivery...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The specific...
- The Defense Logistics Agency awarded a $3,106.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vitamin K-1 10 mg/ml ampules, valued at $3,568.08 under a firm fixed-price contract type. The award was made on June 25, 2025, with an ultimate completion date of June 26, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,487.36 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra, a prothrombin complex concentrate used for emergency reversal of warfarin anticoagulation. The award, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. DMS Pharmaceutical Group Inc., a woman-owned...
- The Defense Logistics Agency awarded a $15,116.82 delivery order to AmerisourceBergen Drug Corp for the supply of Kengreal 50 mg vials, with a completion date of January 5, 2026. The contract employs firm fixed-price pricing and was awarded on January 2, 2026, without a set-aside designation, indicating competitive selection. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZVFDelivery Order
The Defense Logistics Agency awarded a $2,801.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500-unit vials of Kcentra on January 15, 2026, with an ultimate completion date of February 6, 2026. This delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The award was made on a fully competitive basis with no set-aside designation, demonstrating the contractor's capability to compete against other qualified vendors in the federal pharmaceutical supply market. Kcentra, a prothrombin complex concentrate used for urgent reversal of vitamin K antagonist anticoagulation therapy, will be delivered to the place of performance in Conshohocken, Pennsylvania. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare programs worldwide, the Defense Health Agency, and other government healthcare systems. This delivery order exemplifies the company's role in providing specialized pharmaceutical products essential to military and federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/14/26 |